1. Home
  2. MFIC vs EVO Comparison

MFIC vs EVO Comparison

Compare MFIC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MidCap Financial Investment Corporation

MFIC

MidCap Financial Investment Corporation

HOLD

Current Price

$10.93

Market Cap

873.1M

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.07

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFIC
EVO
Founded
2004
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
873.1M
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MFIC
EVO
Price
$10.93
$3.07
Analyst Decision
Hold
Strong Buy
Analyst Count
7
1
Target Price
$11.25
$7.00
AVG Volume (30 Days)
652.6K
47.1K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
10.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
N/A
$10.05
P/E Ratio
$10.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.48
$2.31
52 Week High
$13.51
$4.42

Technical Indicators

Market Signals
Indicator
MFIC
EVO
Relative Strength Index (RSI) 43.77 56.03
Support Level $10.48 $2.88
Resistance Level $11.81 $3.75
Average True Range (ATR) 0.26 0.07
MACD -0.02 0.01
Stochastic Oscillator 32.28 89.58

Price Performance

Historical Comparison
MFIC
EVO

About MFIC MidCap Financial Investment Corporation

MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. The investment objective of the company is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: